Zhaofang Bai

3.4k total citations · 1 hit paper
113 papers, 2.3k citations indexed

About

Zhaofang Bai is a scholar working on Pharmacology, Molecular Biology and Epidemiology. According to data from OpenAlex, Zhaofang Bai has authored 113 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Pharmacology, 45 papers in Molecular Biology and 24 papers in Epidemiology. Recurrent topics in Zhaofang Bai's work include Drug-Induced Hepatotoxicity and Protection (47 papers), Inflammasome and immune disorders (30 papers) and Pharmacological Effects of Natural Compounds (22 papers). Zhaofang Bai is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (47 papers), Inflammasome and immune disorders (30 papers) and Pharmacological Effects of Natural Compounds (22 papers). Zhaofang Bai collaborates with scholars based in China, United States and Macao. Zhaofang Bai's co-authors include Xiaohe Xiao, Xiaoyan Zhan, Guang Xu, Jiabo Wang, Ming Niu, Zhilei Wang, Ruisheng Li, Wei Shi, Yuming Guo and Jiabo Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecular Cell and Hepatology.

In The Last Decade

Zhaofang Bai

109 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors

2023 93 citations Xiaoyan Zhan, Qiang Li et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhaofang Bai China	24	1.3k	823	442	315	291	113	2.3k
Ming Niu China	29	1.2k 1.0×	887 1.1×	188 0.4×	393 1.2×	336 1.2×	134	2.5k
Yanling Zhao China	22	848 0.7×	441 0.5×	166 0.4×	292 0.9×	322 1.1×	76	1.9k
Li‐Hua Lian China	31	1.0k 0.8×	540 0.7×	318 0.7×	679 2.2×	301 1.0×	96	2.4k
Ji‐Xing Nan China	37	1.5k 1.2×	830 1.0×	259 0.6×	901 2.9×	480 1.6×	122	3.4k
Graham R. Betton United Kingdom	15	583 0.5×	501 0.6×	232 0.5×	124 0.4×	254 0.9×	34	2.2k
Feifei Guo China	22	1.5k 1.2×	365 0.4×	261 0.6×	423 1.3×	125 0.4×	95	2.7k
Chen-Huan Yu China	27	861 0.7×	180 0.2×	208 0.5×	371 1.2×	363 1.2×	72	2.1k
Mengyang Liu China	28	793 0.6×	188 0.2×	295 0.7×	424 1.3×	109 0.4×	107	2.2k
Bidya Dhar Sahu India	26	745 0.6×	291 0.4×	146 0.3×	127 0.4×	215 0.7×	58	2.1k
Yunxia Li China	19	695 0.5×	323 0.4×	234 0.5×	386 1.2×	246 0.8×	56	1.6k

Countries citing papers authored by Zhaofang Bai

Since Specialization

Citations

This map shows the geographic impact of Zhaofang Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhaofang Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhaofang Bai more than expected).

Fields of papers citing papers by Zhaofang Bai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhaofang Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhaofang Bai. The network helps show where Zhaofang Bai may publish in the future.

Co-authorship network of co-authors of Zhaofang Bai

This figure shows the co-authorship network connecting the top 25 collaborators of Zhaofang Bai. A scholar is included among the top collaborators of Zhaofang Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhaofang Bai. Zhaofang Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Chengwei, Ran Xu, Simin Chen, et al.. (2025). Salvia miltiorrhiza water extract ameliorated cGAS-STING-mediated acute liver injury by blocking interaction between STING and TBK1. Chinese Herbal Medicines. 17(4). 768–778. 1 indexed citations

Xu, Guang, Ling Li, Xiu Ye, et al.. (2025). Carnosic Acid Directly Targets STING C‐Terminal Tail to Improve STING‐Mediated Inflammatory Diseases. Advanced Science. 12(14). e2417686–e2417686. 7 indexed citations

He, Xian, Ang Huang, Zherui Liu, et al.. (2025). Analysis of Immunometabolic Profiles in Patients With Chronic Drug‐Induced Liver Injury and Validation in Mice to Reveal Potential Mechanisms. Journal of Gastroenterology and Hepatology. 40(4). 987–1003. 1 indexed citations

Yang, Yan, Chen Luo, Yunhao Yang, et al.. (2024). An Experimental Animal Study: Electroacupuncture Facilitates Antiviral Immunity Against Hepatitis B Virus Through the IFN-γ/JAK/STAT Axis. Journal of Inflammation Research. Volume 17. 6547–6562.

Li, Chengwei, Xiaoyan Zhan, Wei Shi, et al.. (2024). Total tanshinones ameliorates cGAS-STING-mediated inflammatory and autoimmune diseases by affecting STING-IRF3 binding. Chinese Medicine. 19(1). 107–107. 2 indexed citations

Li, Hui, et al.. (2024). Wedelolactone suppresses breast cancer growth and metastasis via regulating TGF-β1/Smad signaling pathway. Journal of Pharmacy and Pharmacology. 76(8). 1038–1050. 3 indexed citations

Xiong, Yüting, Tingting He, Junjie Li, et al.. (2024). Protective effects of Nogo-B deficiency in NAFLD mice and its multiomics analysis of gut microbiology and metabolism. Genes & Nutrition. 19(1). 17–17. 1 indexed citations

Bai, Zhaofang, et al.. (2024). Anoectochilus roxburghii polysaccharide reduces D-GalN/LPS-induced acute liver injury by regulating the activation of multiple inflammasomes. Journal of Pharmacy and Pharmacology. 76(9). 1212–1224. 3 indexed citations

Wang, Yan, Guang Xu, Xiaomei Zhao, et al.. (2024). Flavonoid extracted from Epimedium attenuate cGAS‐STING‐mediated diseases by targeting the formation of functional STING signalosome. Immunology. 172(2). 295–312. 10 indexed citations

10.

Zhao, Jia, Hongbin Liu, Zhixian Hong, et al.. (2023). Tanshinone I specifically suppresses NLRP3 inflammasome activation by disrupting the association of NLRP3 and ASC. Molecular Medicine. 29(1). 84–84. 18 indexed citations

11.

Li, Hui, Wei Shi, Ziying Wei, et al.. (2023). Network pharmacology-based strategy for predicting therapy targets of Ecliptae Herba on breast cancer. Medicine. 102(41). e35384–e35384. 14 indexed citations

12.

Wang, Zhilei, et al.. (2022). NLRP3 Inflammasome Pharmacological Inhibitors in Glycyrrhiza for NLRP3-Driven Diseases Treatment: Extinguishing the Fire of Inflammation. SHILAP Revista de lepidopterología. 21 indexed citations

13.

Li, Qiang, Hui Li, Xiaoyan Zhan, et al.. (2022). Polysaccharide extract from Isatidis Radix inhibits multiple inflammasomes activation and alleviate gouty arthritis. Phytotherapy Research. 36(8). 3295–3312. 17 indexed citations

14.

Xu, Guang, Ziying Wei, Zhilei Wang, et al.. (2022). The role of NLRP3 inflammasome in psychotropic drug-induced hepatotoxicity. Cell Death Discovery. 8(1). 313–313. 12 indexed citations

15.

Zhao, Jing, et al.. (2022). Schisandra chinensis essential oil attenuates acetaminophen-induced liver injury through alleviating oxidative stress and activating autophagy. Pharmaceutical Biology. 60(1). 958–967. 10 indexed citations

16.

Wang, Shufeng, Xinzheng Wang, Xin Yang, et al.. (2021). Comprehensive kinomic study via a chemical proteomic approach reveals kinome reprogramming in hepatocellular carcinoma tissues. PROTEOMICS. 22(4). e2100141–e2100141. 2 indexed citations

17.

Qin, Qin, Guang Xu, Xiaoyan Zhan, et al.. (2021). Brevilin A inhibits NLRP3 inflammasome activation in vivo and in vitro by acting on the upstream of NLRP3-induced ASC oligomerization. Molecular Immunology. 135. 116–126. 20 indexed citations

18.

Guo, Yuming, Haibo Song, Peng Xiong, et al.. (2021). Relative Risk Analysis of Liver-related Adverse Drug Reactions in Children Based on China’s National Spontaneous Reporting System. The Journal of Pediatrics. 234. 85–91. 7 indexed citations

19.

Wang, Zhilei, Guang Xu, Yuan Gao, et al.. (2019). Cardamonin from a medicinal herb protects against LPS-induced septic shock by suppressing NLRP3 inflammasome. Acta Pharmaceutica Sinica B. 9(4). 734–744. 98 indexed citations

20.

Qin, Nan, et al.. (2019). Idiosyncratic hepatotoxicity evaluation of Cortex dictamni based on immune stress.. Yaoxue xuebao. 54(4). 678–686. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact